A 56-year-old man with chronic hepatic disease due to hepatitis C and esophageal varices was referred to our hospital with an elevated alpha-fetoprotein level and a solid lesion in the distal common bile duct (CBD) seen on computed tomography (CT) scanning. This lesion was protruding into the second part of the duodenum and causing dilatation of the biliary tree. An upper gastrointestinal endoscopy revealed a raised lesion at the major duodenal papilla (▶ Fig. 1 ). Biopsies showed a tubular adenoma with low grade dysplasia. Endoscopic ultrasound (EUS) revealed thickening that was restricted to the mucosal layer and choledocholithiasis. The patient was not suitable for surgical treatment because of his portal hypertension. We therefore performed an endoscopic papillectomy, followed by a sphincterotomy and placement of a plastic pancreatic stent. A follow-up endoscopy 7 days later revealed a residual lesion with a filling defect in the distal CBD (▶ Fig. 2) . After 30 days, a cholangioscopy was performed using CO 2 and a pediatric gastroscope passed over a guidewire (▶ Fig. 3 ). Biopsies were taken and the residual lesion was treated with argon plasma coagulation (APC) at 20 W and 1.5 L/min (▶ Video 1). The patient remains completely asymptomatic 5 years later, receiving annual follow-up, and having no residual lesions (▶ Fig. 4) . Ampullary adenomas can be found incidentally on endoscopic screening exami-nations and harbor a malignant potential [1] . In a retrospective study, 180 patients who had been treated for ampullary adenomas were followed up for a mean of 4.4 years [2] . There was no difference in endoscopic and operative resection of the ampullary adenomas in terms of local recurrence. However, intraductal
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Video 1 Cholangioscopy performed after papillectomy with a pediatric slim gastroscope revealed a residual lesion in the distal common bile duct. Biopsies were taken and the residual lesion was treated with argon plasma coagulation (APC). 
